13G Filing: Nantahala Capital Management and Aeglea Bio Therapeutics Inc (AGLE)

Page 3 of 7 – SEC Filing

 

CUSIP NO.  00773J103 Page
3 of 7 Pages

 

CUSIP No.  00773J103
(1) Names of reporting persons Wilmot B. Harkey
(2) Check the appropriate box if a member of a group (a)  ¨
(see instructions) (b)  ¨
(3) SEC use only
(4) Citizenship or place of organization USA
Number of shares beneficially owned by each reporting person with:
(5) Sole voting power 0
(6) Shared voting power 1,813,573
(7) Sole dispositive power 0
(8) Shared dispositive power 1,813,573
(9) Aggregate amount beneficially owned by each reporting person 1,813,573
(10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions)  ¨
(11) Percent of class represented by amount in Row (9) 10.9%
(12) Type of reporting person (see instructions) HC

 

 

 

 

Follow Spyre Therapeutics Inc. (NASDAQ:SYRE)